This provides a testament to Leo’s capacity to exert an anti-neoplastic influence on tumor cells, especially those displaying drug resistance, via the modulation of STAT3-related signaling pathways (Kim et al., 2019; Shi et al., 2022). This evidence concerns the gene STAT3 and neoplasm.